comments (0) January 21st, 2020 in gallery     

Pin It

profacgen profacgen, member
Love it! no recommendations

To prove biosimilarity, such an application must include information about analytical studies, animal data, and clinical studies. According to section 351(k) of the PHS act, analytical testings should "demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components." Understandably, analytical testings should be a crucial first step in a biosimilar development program.


Biosimilar Testing Services
posted in: gallery

Comments (0)

You must be logged in to post comments. Click here to login.